ASTAL LABORATORIES LIMITED Share Price

ASTAL LABORATORIES LIMITED Share Price

BSE: 512600
|
Trading
|
S Cap
₹ 71.20
+₹1.58 (2.27%)
1D
Last updated 23 Sep, 2026, 15:29 IST

ASTAL LABORATORIES LIMITED Share Price Today

As of 24 Sep 2026, ASTAL LABORATORIES LIMITED share price is ₹71.20. The stock opened at ₹69.90, compared to its previous close of ₹69.62. During today's trading session, ASTAL LABORATORIES LIMITED share price moved in the range of ₹69.90 to ₹72.40, with an average price of ₹71.15 for the day. Looking at its last 52-week, the stock has touched a low of ₹60.45 and a high of ₹103.20.

₹69.90
2.27% up today
₹72.40
1D LOW
1D HIGH

ASTAL LABORATORIES LIMITED Returns Calculator

Circuit
L
H
₹55.70
₹83.54
52-week
L
H
₹60.45
₹103.20

About ASTAL LABORATORIES LIMITED

ASTAL LABORATORIES LIMITED Share Price
ISIN
INE307N01014
Sector Market Cap
₹ 304.93 Cr

Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.

ASTAL LABORATORIES LIMITED Financial Highlights

  • Revenue: ASTAL LABORATORIES LIMITED reported revenue of ₹249.35 crore in FY26 vs ₹64.36 crore in FY25. It showed an increase of 287.43% on a yearly basis.
  • Operating Profit: ASTAL LABORATORIES LIMITED reported an operating profit of ₹17.73 crore in FY26 vs ₹11.98 crore in FY25. It showed an increase of 48.00% on a year-on-year basis.
  • Net Profit: ASTAL LABORATORIES LIMITED reported a net profit of ₹14.71 crore in FY26 vs ₹8.93 crore in FY25. It showed an increase of 64.73% on a yearly basis.

ASTAL LABORATORIES LIMITED Quarterly Result Highlights

  • ASTAL LABORATORIES LIMITED reported revenue of ₹101.08 crore in Jun 2026, compared with ₹134.15 crore in Mar 2026, representing a decrease of 24.65% on a quarter-on-quarter (QoQ) basis.
  • ASTAL LABORATORIES LIMITED reported an operating profit of ₹10.35 crore in Jun 2026, compared with ₹8.34 crore in Mar 2026, representing an increase of 24.10% on a quarter-on-quarter (QoQ) basis.
  • ASTAL LABORATORIES LIMITED reported a profit of ₹9.42 crore in Jun 2026, compared with ₹7.68 crore in Mar 2026, reflecting an increase of 22.66% on a QoQ basis.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
4.53%
FII
0.00%
Other DII
0.00%
Retail and other
95.47%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
May 20260.00%
Jun 20260.00%
Mkt Cap Cr
304.93
P/E
20.90
P/B
0.90
ROE
4.41%
D/E
0.04
ROCE
5.15%
Div. Yield
0.00%
EPS(TTM)
4.76
Turnover
0.43
EV/EBITDA
11.59
Net Margin
0.00%
Op. Margin
0.00%
ROA
4.28%
Quick Ratio
0.00
Curr. Ratio
1.74
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Astal Lab has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Astal Lab appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Astal Lab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ASTAL LABORATORIES LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2026
Revenue64.36249.35
Operating profit11.9817.73
Net profit8.9314.71

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹64.23₹23.65₹3.43₹0.00
Other Income₹0.13₹0.01₹0.18₹0.21
Total Revenue₹64.36₹23.66₹3.61₹0.21
Total Expenses₹52.38₹22.57₹3.57₹0.23
Profit Before Tax₹11.98₹1.09₹0.03-₹0.02
Tax₹3.05₹0.30₹0.02₹0.00
Profit After Tax₹8.93₹0.78₹0.02-₹0.02
EPS - Basic₹9.08₹1.55₹0.04-₹0.04
EPS - Diluted₹8.04₹1.55₹0.04-₹0.04

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹11.98₹1.09₹0.03-₹0.02
Income before WC changes₹12.78₹1.11-₹0.14-₹0.21
Change in Assets-₹23.36-₹14.62-₹5.95₹0.03
Change in Liabilities-₹1.63₹7.96₹4.66-₹0.06
Change in WC-₹24.99-₹6.66-₹1.29-₹0.04
Cash flow from Operations-₹12.52-₹5.58-₹1.44-₹0.25
Cash flow from Investing-₹7.81-₹6.11₹1.50₹0.24
Cash flow from Financing₹3.29₹17.68₹0.00₹0.00
Total Cash Flow-₹17.04₹5.99₹0.07-₹0.01
Cash (Start of the year)₹6.08₹0.08₹0.02₹0.03
Cash (End of the year)-₹10.96₹6.08₹0.08₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹17.70₹9.89₹3.79₹5.13
Current Assets₹45.64₹26.73₹6.11₹0.10
Total Assets₹63.34₹36.61₹9.91₹5.23
Current Liabilities₹26.77₹13.01₹4.73₹0.07
Net Current Asset₹18.87₹13.72₹1.38₹0.03
Non-Current Liabilities₹0.57₹0.26₹0.00₹0.00
Equity Capital₹35.99₹23.34₹5.18₹5.16
Total Equity & Liabilities₹63.34₹36.61₹9.91₹5.23
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
37.62
Neutral
ATR (14)
4.72
Neutral
STOCH(9,6)
25.33
Neutral
STOCH RSI (14)
34.64
Neutral
ADX(9)
35.53
Bearish
UO(9)
35.06
Neutral
ROC(12)
-7.41
Bearish
WillR(14)
-52.14
Neutral
Period
Simple value
Exponential vaue
5D
70.82
71.24
10D
73.17
72.78
20D
75.91
75.18
50D
79.7
77.93
100D
78.91
78.39
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ASTAL LABORATORIES LIMITED Share Price
ASTAL LABORATORIES LIMITED
Trading
Add Stock
Add Another

ASTAL LABORATORIES LIMITED Share Price FAQs

ASTAL LABORATORIES LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837